Rosa Gini, PhD

Agenzia Reg Della Sanit, Italy

Poster(s):

• (8) Brodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) Study of a Biological Anti-Psoriatic Drug Across Six European Countries
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (153) Data Source Heterogeneity in Multi-Data Base Pharmacoepidemiologic Studies: An ISPE-sponsored Scoping Review
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (Z) COVID-19 Infection and Medication Use in Pregnancy (CONSIGN) – A Multinational Drug Utilisation Study Using Linked Healthcare Data
  Sunday, August 28, 2022

  8:00 AM – 6:00 PM CEST

• (AP) Cohort Monitoring of 29 Adverse Events of Special Interest Prior to and After COVID-19 Vaccination in Four Large European Data Sources
  Sunday, August 28, 2022

  8:00 AM – 1:15 PM CEST

• (AO) Heterogeneity Across European Electronic Healthcare Data Sources: Identification of Adverse Events of Special Interest (AESI) and Impact in Multi-Databases Assessment - An ACCESS Study
  Sunday, August 28, 2022

  8:00 AM – 1:15 PM CEST

• (10) Exploring The Relationship Between Utilization Patterns of Biologic Disease-Modifying Anti-Rheumatic Drugs and Disease Activity in Rheumatoid Arthritis Patients
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (198) Extracting Pregnancies from Heterogeneous Data Sources in Europe: A Novel Algorithm in The Conception Project
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (115) Evaluation of Drug-Utilization and Healthcare Facilities Use in Patients with Ulcerative Colitis and Treated with Biologic Therapy Using Data of An Italian Healthcare Administrative Database: Results from MICHELANGELO Study
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (166) MINERVA: Metadata for Data Discoverability and Study Replicability in Observational Studies
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (116) Real-World Patterns and Trends of Idarucizumab Use in An Italian Region: A Probabilistic Record-Linkage Approach in The Period 2015-2020
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (137) Study Scripts Supporting Multiple Common Data Models
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (127) Use of Riluzole Beyond Approved Therapeutic Indications in Three Italian Regions
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (282) Validation to Estimate Sensitivity Along with Positive Predictive Value: A Case Study
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST